WAYFIND-R

About this trial

WAYFIND-R is a global registry that will collect data from patients who have been diagnosed with a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.

Patient Profile

For patients who have been diagnosed with a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.

Where’s this trial being run?

St James’s Hospital, Tallaght University Hospital, and St Vincents University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: WAYFIND-R
Number: 21-30
Full Title:

WAYFIND-R:A global registry collecting RWD (real world data)
throughout the patient journey from patients with solid tumors who have undergone NGS-based genomic profiling.

Principal Investigator: Prof. Ray McDermott
Type: Industry Sponsored
Sponsor:

ROCHE

Recruitment Started: Global:
Ireland:
Global Recruitment Target: >15,000 patients in approx. 10 countries
Ireland Recruitment Target: 300